B44.89 Other forms of aspergillosis

Name of the Condition

• Other forms of aspergillosis

Summary

Other forms of aspergillosis represent non-invasive or localized infections caused by Aspergillus species, distinct from invasive pulmonary or allergic manifestations. These conditions typically involve colonization of specific tissues or structures without systemic spread, with clinical presentations varying based on host immunity and site of involvement. The spectrum includes conditions like sinus aspergillosis, cutaneous aspergillosis, or localized extrapulmonary disease.

Causes

The condition is caused by Aspergillus species, ubiquitous environmental molds. Spores are inhaled or introduced through direct contact with mucosal surfaces or skin. In susceptible hosts, the fungus may colonize pre-existing cavities, sinuses, or damaged tissue. Unlike invasive disease, the organism does not invade blood vessels or spread systemically, but it can cause localized inflammation or structural changes in the affected area.

Risk Factors

• Chronic sinus disease or prior sinus surgery.
• Skin trauma or burns, particularly in immunocompromised individuals.
• Structural abnormalities in the sinuses or other anatomical sites.
• Prolonged corticosteroid use or mild immunosuppression.
• Environmental exposure to high Aspergillus spore concentrations.
• Prior lung disease with cavitation or bronchiectasis.

Symptoms

• Sinus pain, nasal congestion, or discharge (in sinus involvement).
• Skin lesions, ulcers, or nodules (in cutaneous cases).
• Localized pain, swelling, or discharge at the site of infection.
• Chronic cough or respiratory symptoms if airways are involved.
• Fatigue or low-grade fever in some cases.

Diagnosis

Diagnosis involves clinical evaluation of symptoms and exposure history, followed by imaging (e.g., CT scans for sinus or pulmonary involvement) and laboratory testing. Tissue samples or cultures may be obtained to identify Aspergillus species. Biopsies can help rule out invasive disease, and serologic tests may detect fungal antigens or antibodies in some cases.

Treatment Options

Treatment depends on the site and severity of infection. Antifungal medications (e.g., itraconazole, voriconazole) are commonly used. Surgical intervention may be necessary to remove infected tissue or address structural abnormalities. For allergic forms, corticosteroids or immunotherapy may be considered. Management of underlying conditions (e.g., sinus disease) is also important.

Prognosis and Follow-Up

Prognosis varies based on the site of infection and host immunity. Localized infections often respond well to treatment, but chronic or recurrent cases may require long-term management. Follow-up includes monitoring for recurrence, especially in immunocompromised individuals, and addressing any underlying risk factors.

Complications

• Chronic sinusitis or nasal obstruction.
• Skin scarring or tissue damage.
• Progression to invasive disease in immunocompromised hosts.
• Respiratory impairment if airways are involved.
• Recurrence if underlying conditions are not managed.

Lifestyle & Prevention

• Avoid environments with high mold exposure (e.g., construction sites, damp areas).
• Use protective equipment (e.g., masks) in high-risk settings.
• Manage chronic conditions (e.g., sinus disease, asthma) to reduce susceptibility.
• Practice good wound care to prevent skin infections.
• Maintain immune health through balanced nutrition and avoiding unnecessary immunosuppression.

When to Seek Professional Help

Seek medical attention if symptoms persist or worsen, especially with fever, severe pain, or signs of spreading infection. Immunocompromised individuals should consult a healthcare provider promptly for any new or unusual symptoms, as early intervention is critical.

Tips for Medical Coders

Document the specific site or form of aspergillosis (e.g., sinus, cutaneous) to support code assignment. Include details on clinical presentation, diagnostic findings, and treatment to clarify the condition’s nature. Ensure documentation aligns with the ICD-10-CM guidelines for B44.89, emphasizing non-invasive or localized involvement without systemic spread.